Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia. (BMS)

NCT00211302 is registered in ClinicalTrials.gov with Louisiana State University Health Sciences Center Shreveport as lead sponsor.

NCT NCT00211302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00211302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia. (BMS)
Lead sponsor
Louisiana State University Health Sciences Center Shreveport
Phase
Not applicable
Overall status
Terminated
Start date
August 31, 2003
Completion date
February 28, 2006
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia